Skip to main content
Erschienen in: Intensive Care Medicine 1/2017

05.10.2016 | Original

Increased incidence of co-infection in critically ill patients with influenza

verfasst von: Ignacio Martin-Loeches, Marcus J Schultz, Jean-Louis Vincent, Francisco Alvarez-Lerma, Lieuwe D. Bos, Jordi Solé-Violán, Antoni Torres, Alejandro Rodriguez

Erschienen in: Intensive Care Medicine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Co-infection is frequently seen in critically ill patients with influenza, although the exact rate is unknown. We determined the rate of co-infection, the risk factors and the outcomes associated with co-infection in critically ill patients with influenza over a 7-year period in 148 Spanish intensive care units (ICUs).

Methods

This was a prospective, observational, multicentre study. Influenza was diagnosed using the polymerase chain reaction. Co-infection had to be confirmed using standard bacteriological tests. The primary endpoint of this analysis was the presence of community-acquired co-infection, with secondary endpoints including ICU, 28-day and hospital mortality.

Results

Of 2901 ICU patients diagnosed with influenza, 482 (16.6 %) had a co-infection. The proportion of cases of co-infection increased from 11.4 % (110/968) in 2009 to 23.4 % (80/342) in 2015 (P < 0.001). Compared with patients without co-infection, patients with co-infection were older [adjusted odds ratio (aOR) 1.1, 95 % confidence interval 1.1–1.2; P < 0.001] and were more frequently immunosuppressed due to existing HIV infection (aOR 2.6 [1.5–4.5]; P < 0.001) or preceding medication (aOR 1.4 [1.1–1.9]; P = 0.03). Co-infection was an independent risk factor for ICU mortality (aOR 1.4 [1.1–1.8]; P < 0.02), 28-day mortality (aOR 1.3 [1.1–1.7]; P = 0.04) and hospital mortality (aOR 1.9 [1.5–2.5]; P < 0.001).

Conclusions

Co-infection in critically ill patients with influenza has increased in recent years. In this Spanish cohort, age and immunosuppression were risk factors for co-infection, and co-infection was an independent risk factor for ICU, 28-day and hospital mortality.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Rodríguez A, Díaz E, Martín-Loeches I et al (2011) Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 66:1140–1149. doi:10.1093/jac/dkq511 CrossRefPubMed Rodríguez A, Díaz E, Martín-Loeches I et al (2011) Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A. J Antimicrob Chemother 66:1140–1149. doi:10.​1093/​jac/​dkq511 CrossRefPubMed
3.
Zurück zum Zitat Martin-Loeches I, Bermejo-Martin JF, Valles J et al (2013) Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. Intensive Care Med 39:693–702. doi:10.1007/s00134-013-2829-8 CrossRefPubMed Martin-Loeches I, Bermejo-Martin JF, Valles J et al (2013) Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. Intensive Care Med 39:693–702. doi:10.​1007/​s00134-013-2829-8 CrossRefPubMed
6.
Zurück zum Zitat Giles C, Shuttleworth EM (1957) Postmortem findings in 46 influenza deaths. Lancet (London, England) 273:1224–5 Giles C, Shuttleworth EM (1957) Postmortem findings in 46 influenza deaths. Lancet (London, England) 273:1224–5
10.
Zurück zum Zitat Alfageme I, Aspa J, Bello S et al (2005) Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 41:272–289PubMed Alfageme I, Aspa J, Bello S et al (2005) Guidelines for the diagnosis and management of community-acquired pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR). Arch Bronconeumol 41:272–289PubMed
11.
Zurück zum Zitat Mandell LA, Wunderink G, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72. doi:10.1086/511159 CrossRefPubMed Mandell LA, Wunderink G, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(Suppl 2):S27–S72. doi:10.​1086/​511159 CrossRefPubMed
12.
Zurück zum Zitat Schoenfeld DA, Bernard GR, Network ARDS (2002) Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30:1772–1777CrossRefPubMed Schoenfeld DA, Bernard GR, Network ARDS (2002) Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30:1772–1777CrossRefPubMed
13.
Zurück zum Zitat Martín-Loeches I, Sanchez-Corral A, Diaz E et al (2011) Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest 139:555–562. doi:10.1378/chest.10-1396 CrossRefPubMed Martín-Loeches I, Sanchez-Corral A, Diaz E et al (2011) Community-acquired respiratory coinfection in critically ill patients with pandemic 2009 influenza A(H1N1) virus. Chest 139:555–562. doi:10.​1378/​chest.​10-1396 CrossRefPubMed
16.
Zurück zum Zitat Martin-Loeches I, Lisboa T, Rhodes A, et al. (2010) Use of corticosteroid therapy in patients affected by severe pandemic (H1N1) V influenza A infection. Intensive Care Med. pp S319–S319 Martin-Loeches I, Lisboa T, Rhodes A, et al. (2010) Use of corticosteroid therapy in patients affected by severe pandemic (H1N1) V influenza A infection. Intensive Care Med. pp S319–S319
18.
20.
Zurück zum Zitat Muscedere J, Ofner M, Kumar A et al (2013) The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest 144:39–47. doi:10.1378/chest.12-1861 CrossRefPubMed Muscedere J, Ofner M, Kumar A et al (2013) The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection. Chest 144:39–47. doi:10.​1378/​chest.​12-1861 CrossRefPubMed
21.
Zurück zum Zitat Klein EY, Monteforte B, Gupta A et al (2016) The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influ Other Respi Viruses 10:394–403. doi:10.1111/irv.12398 CrossRef Klein EY, Monteforte B, Gupta A et al (2016) The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influ Other Respi Viruses 10:394–403. doi:10.​1111/​irv.​12398 CrossRef
23.
Zurück zum Zitat Martin-Loeches I, Lisboa T, Rodriguez A et al (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36:612–620CrossRefPubMed Martin-Loeches I, Lisboa T, Rodriguez A et al (2010) Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med 36:612–620CrossRefPubMed
24.
Zurück zum Zitat Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404. doi:10.1016/S2213-2600(14)70041-4 CrossRefPubMed Muthuri SG, Venkatesan S, Myles PR et al (2014) Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2:395–404. doi:10.​1016/​S2213-2600(14)70041-4 CrossRefPubMed
25.
Zurück zum Zitat Vallés J, Martin-Loeches I, Torres A et al (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med. doi:10.1007/s00134-014-3239-2 PubMed Vallés J, Martin-Loeches I, Torres A et al (2014) Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study. Intensive Care Med. doi:10.​1007/​s00134-014-3239-2 PubMed
28.
Zurück zum Zitat Fowlkes A, Steffens A, Temte J et al (2015) Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13. Lancet Respir Med 3:709–718. doi:10.1016/S2213-2600(15)00278-7 CrossRefPubMed Fowlkes A, Steffens A, Temte J et al (2015) Incidence of medically attended influenza during pandemic and post-pandemic seasons through the Influenza Incidence Surveillance Project, 2009-13. Lancet Respir Med 3:709–718. doi:10.​1016/​S2213-2600(15)00278-7 CrossRefPubMed
Metadaten
Titel
Increased incidence of co-infection in critically ill patients with influenza
verfasst von
Ignacio Martin-Loeches
Marcus J Schultz
Jean-Louis Vincent
Francisco Alvarez-Lerma
Lieuwe D. Bos
Jordi Solé-Violán
Antoni Torres
Alejandro Rodriguez
Publikationsdatum
05.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 1/2017
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4578-y

Weitere Artikel der Ausgabe 1/2017

Intensive Care Medicine 1/2017 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.